Catalyst Wire Dossier Catalyst Wire Dossier

Avelumab

avelumab · Merck KGaA and Pfizer
Drug timelines are a Plus or Pro feature.

142 regulatory and trial events tracked for Avelumab, covering 2018-03-22 to 2026-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Avelumab Program Rollover Study [Phase 3]

See pricing